AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
Allotransplantation for multiple myeloma
Authors: Alyea, EP Anderson, KC
Citation: Ep. Alyea et Kc. Anderson, Allotransplantation for multiple myeloma, CANCER J, 7(3), 2001, pp. 166-174
Novel biologically based therapies for myeloma
Authors: Anderson, KC
Citation: Kc. Anderson, Novel biologically based therapies for myeloma, CANCER J, 7, 2001, pp. S19-S23
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies
Authors: Treon, SP Mitsiades, C Mitsiades, N Young, G Doss, D Schlossman, R Anderson, KC
Citation: Sp. Treon et al., Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies, J IMMUNOTH, 24(3), 2001, pp. 263-271
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia
Authors: Treon, SP Agus, TB Link, B Rodrigues, G Molina, A Lacy, MQ Fisher, DC Emmanouilides, M Richards, AI Clark, B Lucas, MS Schlossman, R Schenkein, D Lin, B Kimby, E Anderson, KC Byrd, JC
Citation: Sp. Treon et al., CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia, J IMMUNOTH, 24(3), 2001, pp. 272-279
Apoptosis in multiple myeloma: Therapeutic implications
Authors: Chauhan, D Anderson, KC
Citation: D. Chauhan et Kc. Anderson, Apoptosis in multiple myeloma: Therapeutic implications, APOPTOSIS, 6(1-2), 2001, pp. 47-55
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma andother neoplasias
Authors: Mitsiades, N Mitsiades, CS Poulaki, V Anderson, KC Treon, SP
Citation: N. Mitsiades et al., Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma andother neoplasias, EXPERT OP I, 10(8), 2001, pp. 1521-1530
Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors:new tricks from a (not so) old drug
Authors: Mitsiades, N Poulaki, V Mitsiades, CS Anderson, KC
Citation: N. Mitsiades et al., Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors:new tricks from a (not so) old drug, EXPERT OP I, 10(6), 2001, pp. 1075-1084
Biologic sequelae of interleukin-6 induced P13-K/Akt signaling in multiplemyeloma
Authors: Hideshima, T Nakamura, N Chauhan, D Anderson, KC
Citation: T. Hideshima et al., Biologic sequelae of interleukin-6 induced P13-K/Akt signaling in multiplemyeloma, ONCOGENE, 20(42), 2001, pp. 5991-6000
The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications
Authors: Hideshima, T Chauhan, D Schlossman, R Richardson, P Anderson, KC
Citation: T. Hideshima et al., The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications, ONCOGENE, 20(33), 2001, pp. 4519-4527
Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology
Authors: Schiffer, CA Anderson, KC Bennett, CL Bernstein, S Elting, LS Goldsmith, M Goldstein, M Hume, H McCullough, JJ McIntyre, RE Powell, BL Rainey, JM Rowley, SD Rebulla, P Troner, MB Wagnon, AH
Citation: Ca. Schiffer et al., Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology, J CL ONCOL, 19(5), 2001, pp. 1519-1538
CD6+donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors
Authors: Soiffer, RJ Weller, E Alyea, EP Mauch, P Webb, IL Fisher, DC Freedman, AS Schlossman, RL Gribben, J Lee, S Anderson, KC Marcus, K Stone, RM Antin, JH Ritz, J
Citation: Rj. Soiffer et al., CD6+donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors, J CL ONCOL, 19(4), 2001, pp. 1152-1159
Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial
Authors: Stewart, AK Vescio, R Schiller, G Ballester, O Noga, S Rugo, H Freytes, C Stadtmauer, E Tarantolo, S Sahebi, F Stiff, P Meharchard, J Schlossman, R Brown, R Tully, H Benyunes, M Jacobs, C Berenson, R White, M DiPersio, J Anderson, KC Berenson, J
Citation: Ak. Stewart et al., Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial, J CL ONCOL, 19(17), 2001, pp. 3771-3779
Introduction: New approaches to the treatment of multiple myeloma
Authors: Anderson, KC
Citation: Kc. Anderson, Introduction: New approaches to the treatment of multiple myeloma, SEMIN ONCOL, 28(6), 2001, pp. 535-535
Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma
Authors: D'Amato, RJ Lentzsch, S Anderson, KC Rogers, MS
Citation: Rj. D'Amato et al., Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma, SEMIN ONCOL, 28(6), 2001, pp. 597-601
Novel therapies targeting the myeloma cell and its bone marrow microenvironment
Authors: Hideshima, T Chauhan, D Podar, K Schlossman, RL Richardson, P Anderson, KC
Citation: T. Hideshima et al., Novel therapies targeting the myeloma cell and its bone marrow microenvironment, SEMIN ONCOL, 28(6), 2001, pp. 607-612
Targeted therapy for multiple myeloma
Authors: Anderson, KC
Citation: Kc. Anderson, Targeted therapy for multiple myeloma, SEM HEMATOL, 38(3), 2001, pp. 286-294
Advances in disease biology: Therapeutic implications
Authors: Anderson, KC
Citation: Kc. Anderson, Advances in disease biology: Therapeutic implications, SEM HEMATOL, 38(2), 2001, pp. 6-10
Single neurons in prefrontal cortex encode abstract rules
Authors: Wallis, JD Anderson, KC Miller, EK
Citation: Jd. Wallis et al., Single neurons in prefrontal cortex encode abstract rules, NATURE, 411(6840), 2001, pp. 953-956
Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells
Authors: Chauhan, D Hideshima, T Rosen, S Reed, JC Kharbanda, S Anderson, KC
Citation: D. Chauhan et al., Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells, J BIOL CHEM, 276(27), 2001, pp. 24453-24456
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells
Authors: Hideshima, T Richardson, P Chauhan, D Palombella, VJ Elliott, PJ Adams, J Anderson, KC
Citation: T. Hideshima et al., The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells, CANCER RES, 61(7), 2001, pp. 3071-3076
A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2
Authors: Schultze, JL Anderson, KC Gilleece, MH Gribben, JG Nadler, LM
Citation: Jl. Schultze et al., A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2, BR J HAEM, 113(2), 2001, pp. 455-460
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
Authors: Mitsiades, CS Treon, SP Mitsiades, N Shima, Y Richardson, P Schlossman, R Hideshima, T Anderson, KC
Citation: Cs. Mitsiades et al., TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications, BLOOD, 98(3), 2001, pp. 795-804
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
Authors: Podar, K Tai, YT Davies, FE Lentzsch, S Sattler, M Hideshima, T Lin, BK Gupta, D Shima, Y Chauhan, D Mitsiades, C Raje, N Richardson, P Anderson, KC
Citation: K. Podar et al., Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration, BLOOD, 98(2), 2001, pp. 428-435
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
Authors: Davies, FE Raje, N Hideshima, T Lentzsch, S Young, G Tai, YT Lin, B Podar, K Gupta, D Chauhan, D Treon, SP Richardson, PG Schlossman, RL Morgan, GJ Muller, GW Stirling, DI Anderson, KC
Citation: Fe. Davies et al., Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma, BLOOD, 98(1), 2001, pp. 210-216
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis
Authors: Raje, N Kica, G Chauhan, D Zhang, YN Teoh, G Treon, SP Hideshima, T Deng, JH Gao, SJ Alsina, M Wally, J Davies, FE Tai, YT Pinkus, GS Pinkus, JL Skinner, M Comenzo, RL Anderson, KC
Citation: N. Raje et al., Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis, AMYLOID, 7(2), 2000, pp. 126-132
Risultati: 1-25 | 26-50 | 51-61